Zura Bio Ltd
Data quality: 83%
ZURA
Nasdaq
Manufacturing
Chemicals
$5.62
▼
$0.08
(-1.39%)
Mkt Cap: 533.32 M
Price
$5.62
Mkt Cap
533.32 M
Day Range
$5.55 — $5.81
52-Week Range
$0.98 — $7.44
Volume
407,352
Open $5.67
50D / 200D Avg
$6.26
10.15% below
50D / 200D Avg
$3.82
47.19% above
Quick Summary
Key Takeaways
Negative free cash flow of -64.93 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-58.64%
Below sector avg (-53.41%)
ROIC-46.16%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio5.58
Interest CoverageN/A
Valuation
PE (TTM)
-7.77
Below sector avg (-1.48)
P/B Ratio4.93
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.8 | -1.5 |
| P/B | 4.9 | 1.6 |
| ROE % | -58.6 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -68.65 M |
| ROE | -58.64% | ROA | -45.50% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -64.93 M |
| ROIC | -46.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5.58 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 116.80 M | Tangible Book Value | 108.24 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.77 | Forward P/E | N/A |
| P/B Ratio | 4.93 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -12.17% | ||
| Market Cap | 533.32 M | Enterprise Value | 394.31 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.06 | Revenue / Share | N/A |
| FCF / Share | -0.68 | OCF / Share | -0.68 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 94.58% |
| SBC-Adj. FCF | -83.33 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -68.65 M | -52.40 M | -60.36 M | 6.85 M | 3.55 M |
| EPS (Diluted) | -1.06 | -0.60 | -2.09 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -75.25 M | -55.19 M | -62.64 M | -888,545.0 | -2.68 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 42.08 M | 24.40 M | 44.00 M | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 49,000.0 | 9,000.0 | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | 0.0 | 0.0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 113.95 M | 179.53 M | 100.84 M | 140.55 M | 141.51 M |
| Total Liabilities | 12.41 M | 19.51 M | 21.29 M | 10.35 M | 7.76 M |
| Shareholders' Equity | 101.54 M | 146.82 M | 59.33 M | -9.18 M | -7.63 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 109.41 M | 176.50 M | 99.80 M | 729,223.0 | 13,785.0 |
| Current Assets | 112.31 M | 178.74 M | 100.84 M | 1.15 M | 33,487.0 |
| Current Liabilities | 12.41 M | 19.51 M | 20.30 M | 272,292.0 | 1.83 M |
{"event":"ticker_viewed","properties":{"ticker":"ZURA","listing_kind":"stock","pathname":"/stocks/zura","exchange":"Nasdaq","country":"US"}}